In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...

Single-cell biology has transformed how we decode cellular heterogeneity, but a new frontier is emerging: understanding what individual cells do, not just what they express. The ability to observe ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research ...